ClinicalTrials.Veeva

Menu

Surgical Margin Assessment by 3D Ultrasound

Rigshospitalet logo

Rigshospitalet

Status

Enrolling

Conditions

Squamous Cell Carcinoma
Head and Neck Cancer
Tongue Cancer

Treatments

Diagnostic Test: 3D ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT05740774
21017915a

Details and patient eligibility

About

Complete removal of cancer encircled by a secure margin of healthy tissue is the aim of surgical oncology. A close or positive surgical margin reported by pathologist typically ends in adjuvant therapies (re-surgery and/or radiotherapy), which come with prognostic risks and financial cost. Therefore, ex-vivo imaging of removed cancer tissue may assist in margin evaluation. In this study, investigators aimed to investigate the correlation of 3D ultrasound to histopathology to assess tongue tumor margin status.

Enrollment

7 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with biopsy-proven oral tongue squamous cell carcinoma scheduled for surgical treatment
  • T1-T2 staging on cross-sectional imaging

Exclusion criteria

  • Age < 18 yrs
  • T3-T4 staging
  • Unable to understand the verbal or written information
  • Prior radiotherapy treatment of oral cavity cancer

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

7 participants in 1 patient group

Tongue tumor resection
Experimental group
Treatment:
Diagnostic Test: 3D ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Tobias Todsen; Fatemeh Makouei

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems